NASDAQ: PSTI       Pluristem Therapeutc
Last Price Today's Change   Day's Range   Trading Volume
8.31   +0.32 (4.01%)  7.86 - 8.36  397,800


Avg Volume (4 weeks):1,749,363
4 Weeks Range:7.73 - 10.87
4 Weeks Price Volatility (%):
52 Weeks Range:0.397 - 13.29
52 Weeks Price Volatility (%):
Average Price Target: 5.00
Price Target Upside/Downside: -3.31


No recent Headlines for this stock.

Business Background

Pluristem Therapeutics Inc is a US-based company which acts as a developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The lead indications are critical limb ischemia, recovery after surgery for femoral neck fracture, and acute radiation syndrome. The company operations are focused on the research, development, clinical trials and manufacturing of cell therapeutics and related technologies. Pluristem operates through the single business segment being Development of placenta-based cell therapy product.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

2380  5807  509  156 

Top 10 Active Counters
 GE 6.78-0.51 
 GNUS 1.81-0.02 
 HX 1.30+0.82 
 HTZ 1.02-0.29 
 XLF 23.68-0.38 
 SPY 302.97-0.56 
 BAC 24.86-1.12 
 ABIO 19.21+15.26 
 NCLH 16.07-1.52 
 MARK 2.97-0.43 
Partners & Brokers